Decreased risk of wound infection after posterior cervical fusion with routine local application of vancomycin powder

Spine

Volumn 38, Issue 12, 2013, Pages 991-994

  Strom, Russell G ^a   Pacione, Donato ^a   Kalhorn, Stephen P ^b   Frempong Boadu, Anthony K ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Efficacy; Laminectomy; Local antibiotics; Posterior cervical fusion; Pseudarthrosis; Safety; Spine surgery; Vancomycin powder; Wound infection

Indexed keywords

VANCOMYCIN; ANTIINFECTIVE AGENT; POWDER;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; COAGULASE NEGATIVE STAPHYLOCOCCUS; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; GRAM NEGATIVE BACTERIUM; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; NEPHROTOXICITY; OTOTOXICITY; POSTERIOR SPINE FUSION; POWDER; PRIORITY JOURNAL; PSEUDARTHROSIS; RETROSPECTIVE STUDY; SURGICAL INFECTION; ADVERSE EFFECTS; CERVICAL SPINE; INFECTION CONTROL; MICROBIOLOGY; MIDDLE AGED; PROCEDURES; RISK FACTOR; SPINE FUSION; SURGERY; SURGICAL WOUND INFECTION; TIME; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; CERVICAL VERTEBRAE; FEMALE; HUMANS; INFECTION CONTROL; MALE; MIDDLE AGED; POWDERS; RETROSPECTIVE STUDIES; RISK FACTORS; SPINAL FUSION; SURGICAL WOUND INFECTION; TIME FACTORS; TREATMENT OUTCOME; VANCOMYCIN;

EID: 84879110054     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/BRS.0b013e318285b219     Document Type: Article

References (14)

1. Calderone RR, Garland DE, Capen DA, et al. Cost of medical care for postoperative spinal infections. Orthop Clin North Am 1996; 27: 171-82.
2. Collins I, Wilson-MacDonald J, Chami G, et al. The diagnosis and management of infection following instrumented spinal fusion. Eur Spine J 2008; 17: 445-50.
3. Rechtine GR, Bono PL, Cahill D, et al. Postoperative wound infection after instrumentation of thoracic and lumbar fractures. J Orthop Trauma 2001; 15: 566-9.
4. Schimmel JJ, Horsting PP, de Kleuver M, et al. Risk factors for deep surgical site infections after spinal fusion. Eur Spine J 2010; 19: 1711-9.
5. O'Neill KR, Smith JG, Abtahi AM, et al. Reduced surgical site infections in patients undergoing posterior spinal stabilization of traumatic injuries using vancomycin powder. Spine J 2011; 11: 641-6.
6. Wimmer C, Gluch H, Franzreb M, et al. Predisposing factors for infection in spine surgery: a survey of 850 spinal procedures. J Spinal Disord 1998; 11: 124-8.
7. Milstone AM, Maragakis LL, Townsend T, et al. Timing of preoperative antibiotic prophylaxis: a modifiable risk factor for deep surgical site infections after pediatric spinal fusion. Pediatr Infect Dis J 2008; 27: 704-8.
8. Prokuski L. Prophylactic antibiotics in orthopaedic surgery. J Am Acad Orthop Surg 2008; 16: 283-93.
9. Sweet FA, Roh M, Sliva C. Intrawound application of vancomycin for prophylaxis in instrumented thoracolumbar fusions: efficacy, drug levels, and patient outcomes. Spine 2011; 36: 2084-8.
10. Molinari RW, Khera OA, Molinari WJ 3rd. Prophylactic intraoperative powdered vancomycin and postoperative deep spinal wound infection: 1,512 consecutive surgical cases over a 6-year period. Eur Spine J 2012; 21 (suppl 4) : S476-82.
11. Edin ML, Miclau T, Lester GE, et al. Effect of cefazolin and vancomycin on osteoblasts in vitro. Clin Orthop Relat Res 1996: 245-51.
12. Springer BD, Lee GC, Osmon D, et al. Systemic safety of high-dose antibiotic-loaded cement spacers after resection of an infected total knee arthroplasty. Clin Orthop Relat Res 2004: 47-51.
13. Patrick BN, Rivey MP, Allington DR. Acute renal failure associated with vancomycin- and tobramycin-laden cement in total hip arthroplasty. Ann Pharmacother 2006; 40: 2037-42.
14. Rathbone CR, Cross JD, Brown KV, et al. Effect of various concentrations of antibiotics on osteogenic cell viability and activity. J Orthop Res 2011; 29: 1070-4.